; and of which $2,156,848,000 (increased by $2,000,000) (increased by $5,000,000) (increased by $10,000,000) (increased by $7,000,000) (increased by $7,800,000) (increased by $200,000) (increased by $3,000,000) (reduced by $15,000,000) (increased by $15,000,000), to remain available for obligation until September 30, 2025, shall be for research, development, test and evaluation: Provided, That, notwithstanding any other provision of law, of the amount made available under this heading for research, development, test and evaluation, not less than $12,000,000 shall be available for HIV prevention educational activities undertaken in connection with United States military training, exercises, and humanitarian assistance activities conducted primarily in African nations: Provided further, That of the funds provided under this heading for research, development, test and evaluation, not less than $1,154,000,000 (increased by $2,000,000) (reduced by $842,000) (increased by $842,000) (increased by $9,000,000) (reduced by $9,000,000) shall be made available to the Defense Health Agency to carry out the congressionally directed medical research programs: Provided further, That the Secretary of Defense shall submit to the congressional defense committees quarterly reports on the current status of the electronic health record program: Provided further, That the Comptroller General of the United States shall perform quarterly performance reviews of the electronic health record program. Chemical agents and munitions destruction, defense For expenses, not otherwise provided for, necessary for the destruction of the United States stockpile of lethal chemical agents and munitions in accordance with the provisions of section 1412 of the Department of Defense Authorization Act, 1986 ( 50 U.S.C. 1521 ), and for the destruction of other chemical warfare materials that are not in the chemical weapon stockpile, $1,091,844,000, of which $89,284,000 shall be for operation and maintenance, of which no less than $57,875,000 shall be for